Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 175

1.

Phase 3 adaptive trial design options in treatment of complicated urinary tract infection.

Viele K, Mundy LM, Noble RB, Li G, Broglio K, Wetherington JD.

Pharm Stat. 2018 Aug 27. doi: 10.1002/pst.1892. [Epub ahead of print]

PMID:
30152129
2.

A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia.

Mundy LM, Wohlfeil S.

Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25204. [Epub ahead of print] No abstract available.

PMID:
29981266
3.

Infection Prevention and Control in Asia: Current Evidence and Future Milestones.

Apisarnthanarak A, Mundy LM, Tantawichien T, Leelarasamee A.

Clin Infect Dis. 2017 May 15;64(suppl_2):S49-S50. doi: 10.1093/cid/cix071. No abstract available.

4.

Community-Acquired Pneumonia Case Validation in an Anonymized Electronic Medical Record-Linked Expert System.

Mukhopadhyay A, Maliapen M, Ong V, Jakes RW, Mundy LM, Jialiang L, Tambyah PA.

Clin Infect Dis. 2017 May 15;64(suppl_2):S141-S144. doi: 10.1093/cid/cix020.

PMID:
28475780
5.

National Survey of Infectious Diseases Physicians on Prevention Practices for Multidrug-Resistant Acinetobacter baumannii in Thailand.

Apisarnthanarak A, Buppajarntham A, Mundy LM.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):489-91. doi: 10.1017/ice.2015.343. Epub 2016 Jan 11. No abstract available.

PMID:
26751004
6.

Design and analysis of a pharmacist-enhanced antimicrobial stewardship program in Thailand.

Apisarnthanarak A, Lapcharoen P, Vanichkul P, Srisaeng-Ngoen T, Mundy LM.

Am J Infect Control. 2015 Sep 1;43(9):956-9. doi: 10.1016/j.ajic.2015.05.011. Epub 2015 Jun 19.

PMID:
26095656
7.

Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.

Cates JE, Mitrani-Gold FS, Li G, Mundy LM.

Antimicrob Agents Chemother. 2015 Aug;59(8):4510-20. doi: 10.1128/AAC.00679-15. Epub 2015 May 18.

8.

The utilization of clinical and radiologic tools for the diagnosis of acute appendicitis.

Apisarnthanarak P, Mundy LM, Apisarnthanarak A.

Am J Emerg Med. 2015 Jun;33(6):840-1. doi: 10.1016/j.ajem.2015.03.009. Epub 2015 Mar 14. No abstract available.

PMID:
25819408
9.

Behavior-based interventions to improve hand hygiene adherence among intensive care unit healthcare workers in Thailand.

Apisarnthanarak A, Eiamsitrakoon T, Mundy LM.

Infect Control Hosp Epidemiol. 2015 May;36(5):517-21. doi: 10.1017/ice.2015.1. Epub 2015 Feb 4.

PMID:
25648155
10.

Identifying hospitalized pediatric patients for early discharge planning: a feasibility study.

Holland DE, Conlon PM, Rohlik GM, Gillard KL, Messner PK, Mundy LM.

J Pediatr Nurs. 2015 May-Jun;30(3):454-62. doi: 10.1016/j.pedn.2014.12.011. Epub 2015 Jan 20.

PMID:
25617180
11.

Tuberculin skin test and QuantiFERON-TB Gold In-tube Test for latent tuberculosis in Thai HIV-infected adults.

Khawcharoenporn T, Apisarnthanarak A, Phetsuksiri B, Rudeeaneksin J, Srisungngam S, Mundy LM.

Respirology. 2015 Feb;20(2):340-7. doi: 10.1111/resp.12442. Epub 2014 Nov 26.

12.

Retapamulin prescriptions and monitored off-label use.

Mundy LM, Sampson T, Logie JW.

Paediatr Drugs. 2014 Aug;16(4):331-6. doi: 10.1007/s40272-014-0077-1.

PMID:
24935401
13.

Assessment of the 2007 Thai commitment to the Global Patient Safety Campaign.

Apisarnthanarak A, Bangsong R, Saelao A, Pothirat T, Rutjanawech S, Khawcharoenporn T, Mundy LM.

Am J Infect Control. 2014 Jun;42(6):690-1. doi: 10.1016/j.ajic.2014.02.009. No abstract available.

PMID:
24837125
14.

Asymptomatic eosinophilia due to gnathostomiasis.

Buppajarntham A, Apisarnthanarak A, Khawcharoenporn T, Rutjanawech S, Mundy LM.

Int J Infect Dis. 2014 Jun;23:14-5. doi: 10.1016/j.ijid.2014.01.029. Epub 2014 Mar 20.

15.

Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A.

Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.

PMID:
24613422
16.

Infection prevention control bundle of multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus: which one is more important?

Apisarnthanarak A, Mundy LM.

Infect Control Hosp Epidemiol. 2014 Feb;35(2):207-8. doi: 10.1086/674865. No abstract available.

PMID:
24442090
17.

Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control.

Apisarnthanarak A, Yang Hsu L, Lim TP, Mundy LM.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):98-9. doi: 10.1086/674404. No abstract available.

PMID:
24334810
18.

Carbapenem de-escalation therapy in a resource-limited setting.

Apisarnthanarak A, Bhooanusas N, Yaprasert A, Mundy LM.

Infect Control Hosp Epidemiol. 2013 Dec;34(12):1310-3. doi: 10.1086/673976. Epub 2013 Oct 24.

PMID:
24225617
19.

Associations between carbapenem use, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.

Apisarnthanarak A, Jitpokasem S, Mundy LM.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1235-7. doi: 10.1086/673460. No abstract available.

PMID:
24113616
20.

Hand hygiene behavior: translating behavioral research into infection control practice.

Eiamsitrakoon T, Apisarnthanarak A, Nuallaong W, Khawcharoenporn T, Mundy LM.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1137-45. doi: 10.1086/673446. Epub 2013 Sep 23.

PMID:
24113596

Supplemental Content

Loading ...
Support Center